Novo Nordisk's Diabetes Drug Outshines Ozempic: Buy?
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Uncover ways to enhance credit card points accumulation and earn more rewards. Follow these tips for a more fruitful rewards journey.
17,849 articlesA new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
A major government contract marks a turning point for Palantir. This analysis explains how the DHS deal could reshape...
Cactus (WHD) finishes 2025 with solid top-line growth and steadier margins. This report breaks down cactus (whd) 2025...
As Baidu surges, a hedge fund’s multi-million bet raises questions about AI, China’s digital economy, and portfolio c...
Lucid Group shares fell about 6% as investors grilled the company after a mixed Investor Day, with widening losses an...
Income-focused investing is making waves in 2026. This high-yielding dividend beating ETF has shown resilience as bro...
A high-profile kidnapping tied to crypto ransom ends in an arrest abroad, underscoring risks for the crypto ecosystem...
USC receives a $200 million gift from Mark Stevens and his wife to launch a campuswide AI initiative, marking one of ...
In a year of mixed signals, the best advice is simple: build a durable plan, automate investing, and stay focused on ...
A bipartisan push introduces the American Reserve Modernization Act to create a federal Bitcoin reserve and a Digital...
A small cadre of high-priced stocks stubbornly resist stock splits even as peers embrace them. Here are four names le...
Cardano teams with Brazil's Olympic Committee to modernize sports administration using AI, blockchain, and IoT. ADA r...